Cited by 302Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsNeural and Behavioral Psychology Studies

Neuropsychiatric symptoms in Alzheimer's disease: what might be associated brain circuits?

Open access
Rosenberg, Paul B., Nowrangi, Milap A., Lyketsos, Constantine G.·2015·Molecular Aspects of Medicine

Abstract

Neuropsychiatric symptoms (NPS) are very common in Alzheimer’s disease (AD), particularly agitation, apathy, depression, and delusions. Brain networks or circuits underlying these symptoms are just starting to be understood, and there is a growing imaging and neurochemical evidence base for understanding potential mechanisms for NPS. We offer a synthetic review of the recent literature and offer hypotheses for potential networks/circuits underlying these NPS, particularly agitation, apathy, and delusions. Agitation in AD appears to be associated with deficits in structure and function of frontal cortex, anterior cingulate cortex, posterior cingulate cortex, amygdala, and hippocampus, and may be associated with mechanisms underlying misinterpretation of threats and affective regulation. Apathy in AD is associated with frontal cortex, anterior cingulate cortex, posterior cingulate cortex, as well as orbitofrontal cortex, and inferior temporal cortex, and may be associated with mechanisms underlying avoidance behaviors.

AI snapshot

Written from the paper’s full text.

TL;DR

This synthetic review proposes that neuropsychiatric symptoms in Alzheimer’s disease (AD), especially agitation and apathy, arise from dysfunction in distributed brain networks/circuits rather than single regions. It links agitation to frontal/cingulate/amygdala/insular circuits and apathy to frontal/cingulate/orbitofrontal/insular/inferior temporal circuits, while noting insufficient evidence for depression and psychosis hypotheses.

Key findings

  • Agitation in AD was consistently associated with volume loss in frontal cortex, anterior cingulate cortex (ACC), posterior cingulate cortex (PCC), insula, amygdala, and hippocampus; autopsy studies concurred on decreased cholinergic markers, particularly in frontal and temporal cortex, and decreased serotonin/metabolites, with higher tau/phospho-tau and decreased PB2A enzymatic activity in frontal cortex.
  • Apathy in AD was associated with ACC damage (reduced gray matter volume, cortical thinning, decreased perfusion, decreased white matter integrity, and increased amyloid burden in right ACC), PCC hypometabolism, frontal volume loss/cortical thinning, greater bilateral frontal amyloid burden, reduced orbitofrontal metabolism, decreased insula volume, and decreased inferior temporal cortical thickness; one CSF study of 32 AD subjects found apathy severity associated with higher CSF tau and phospho-tau but not Aβ1–42.
  • Delusions in AD were associated with decreased gray matter volume, perfusion, or metabolism in frontal cortex and ACC, with varied localization to orbitofrontal, dorsolateral, or inferior frontal cortex, plus insula involvement; one raclopride PET study found increased D2/D3 receptor density. Delusions had a 5-year period prevalence of >50% in the longitudinal Cache County study.
  • Depression in AD had very few imaging data: in 334 subjects with MCI, NPI-Q Depression was associated with reduced entorhinal cortical thickness at baseline and accelerated ACC atrophy; in 202 MCI and 85 AD subjects, it was associated with decreased left middle frontal gray matter volume; lower CSF taurine was associated with depression and overall NPS in 202 AD subjects. The paper concludes there is insufficient evidence to generate hypotheses for depression.

Methods

  • Synthetic, not systematic, review of recent literature (last 10 years with selected older studies), focused on AD and excluding other dementias, emphasizing replicated findings where available.
  • Reviewed neuroimaging (MRI, DTI, SPECT perfusion, amyloid PET, resting-state fMRI) and neurochemical/autopsy/CSF studies relevant to agitation, apathy, delusions, and depression in AD.
  • Main analysis is narrative synthesis and hypothesis generation about brain networks/circuits; no primary data collection or meta-analysis.

Limitations

  • Paper-stated: the literature is sparse, making direct comparisons challenging; phenotyping is varied with different NPS definitions and little consideration of symptom overlap; there is no consensus on dimensional vs. categorical definitions; imaging analysis methods vary (ROI vs. VBM); laterality findings are contradictory; some studies are likely underpowered; and there is insufficient evidence for depression or psychosis to develop cogent hypotheses.
  • Evident from the text: most evidence is associative rather than causal; agitation had no neurochemical imaging studies; apathy had only one neurochemical CSF study; delusion studies often did not dissociate delusions from agitation; and the review offers hypotheses rather than confirmatory tests.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1016/j.mam.2015.05.005

Cites

Statistics

Nothing to recompute.

Claims the paper makes

0 of 65 cited sources checked · 0 supported · 0 flagged

  • Findingcitation

    Apathy in Alzheimer's disease is associated with decreased bilateral putamen dopamine transporter density.

    “Of the two reports involving neurochemical imaging, one reported decreased bilateral putamen dopamine transporter density (David et al., 2008) while the other reported no association with D2/D3 dopamine receptor density (Reeves et al., 2009).”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites David et al., 2008 source

      Not checked in the free run.

  • Findingcitation

    Agitation in Alzheimer's disease is associated with hypoperfusion in left anteriotemporal, right parietal, and bilateral dorsofrontal cortex.

    “The sole SPECT perfusion study (Hirono et al., 2000) linked agitation with hypoperfusion in left anteriotemporal, right parietal, and bilateral dorsofrontal cortex.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Hirono et al., 2000 source

      Not checked in the free run.

  • Findingcitation

    Agitation in Alzheimer's disease is associated with volume loss in frontal cortex, anterior cingulate cortex, posterior cingulate cortex, insula, amygdala, and hippocampus.

    “Agitation was consistently associated with volume loss in several specific brain areas including frontal cortex (Hu et al., 2015; Trzepacz et al., 2013b), anterior cingulate cortex (ACC) (Bruen et al., 2008; Trzepacz et al., 2013b), posterior cingulate cortex (PCC) (Hu et al., 2015; Trzepacz et al., 2013b), insula (Bruen et al., 2008; Hu et al., 2015; Trzepacz et al., 2013b), amygdala (Trzepacz et”
    Quote in the paperSubstantial claim0 of 3 sources checked
    • cites Hu et al., 2015

      Not checked in the free run.

    • cites Trzepacz et al., 2013b

      Not checked in the free run.

    • cites Bruen et al., 2008 source

      Not checked in the free run.

  • Findingcitation

    Agitation in Alzheimer's disease is associated with deficits in structure and function of frontal cortex, anterior cingulate cortex, posterior cingulate cortex, amygdala, and hippocampus.

    “Agitation in AD appears to be associated with deficits in structure and function of frontal cortex, anterior cingulate cortex, posterior cingulate cortex, amygdala, and hippocampus, and may be associated with mechanisms underlying misinterpretation of threats and affective regulation.”
    • Also stated in: § 2. Results · plain
      “Agitation was consistently associated with volume loss in several specific brain areas including frontal cortex (Hu et al., 2015; Trzepacz et al., 2013b), anterior cingulate cortex (ACC) (Bruen et al., 2008; Trzepacz et al., 2013b), posterior cingulate cortex (PCC) (Hu et al., 2015; Trzepacz et al., 2013b), insula (Bruen et al., 2008; Hu et al., 2015; Trzepacz et al., 2013b), amygdala (Trzepacz et”
    Quote in the paperSubstantial claim0 of 3 sources checked
    • cites Hu et al., 2015

      Not checked in the free run.

    • cites Trzepacz et al., 2013b

      Not checked in the free run.

    • cites Bruen et al., 2008 source

      Not checked in the free run.

  • Findingcitation

    Apathy in Alzheimer's disease is associated with increased amyloid burden in right anterior cingulate cortex.

    “Similarly apathy is associated with decreased perfusion in ACC (Benoit et al., 2004; Lanctôt et al., 2007; Robert et al., 2006), decreased ACC white matter integrity by DTI (Hahn et al., 2013; Kim et al., 2011; Ota et al., 2012) and increased amyloid burden in right ACC (Mori et al., 2014).”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Mori et al., 2014 source

      Not checked in the free run.

  • May combine two claims. 21
  • Classified as probably not a substantial claim. 15
  • May combine two claims.

    Findingcitation

    Overactivity and/or aggressiveness in Alzheimer's disease are associated with decreased cholinergic markers, particularly in frontal and temporal cortex, and with decreased serotonin and serotonin metabolites.

    “All three studies concur: overactivity and/or aggressiveness were associated with decreased cholinergic markers, particularly in frontal and temporal cortex, and with decreased serotonin and serotonin metabolites.”
    Quote in the paperSubstantial claim0 of 3 sources checked
    • cites Garcia-Alloza et al., 2005 source

      Not checked in the free run.

    • cites Guadagna et al., 2012 source

      Not checked in the free run.

    • cites Minger et al., 2000 source

      Not checked in the free run.

  • May combine two claims.

    Findingcitation

    Agitation in Alzheimer's disease is associated with higher levels of tau and phosphorylated tau, and with decreased PP2A enzymatic activity in frontal cortex.

    “Two studies concur that agitation was associated with higher levels of tau and phosphorylated tau (phospho-tau), association with decreased PB2A enzymatic activity (PB2A is a tau phosphatase) in frontal cortex.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingcitation

    Apathy in Alzheimer's disease is associated with damage to anterior cingulate cortex, as evidenced by decreased structural integrity or perfusion of anterior cingulate cortex, and with increased amyloid burden globally, especially in anterior cingulate cortex.

    “First and foremost, apathy in AD is associated with damage to the ACC as evidenced by decreased structural integrity or perfusion of the ACC, as well as with increased amyloid burden globally (Marshall et al., 2013) especially in ACC.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Marshall et al., 2013 source

      Not checked in the free run.

  • May combine two claims.

    Findingcitation

    Apathy in Alzheimer's disease is associated with greater amyloid burden in bilateral frontal cortex, reduced orbitofrontal metabolism on the left or right, and reduced connectivity in left-sided functional connectivity with frontal cortex.

    “Apathy is further associated with greater amyloid burden in bilateral frontal cortex (Mori et al., 2014), reduced orbitofrontal metabolism on the left (Holthoff et al., 2005) or right (Lanctôt et al., 2007), and reduced connectivity in left-sided functional connectivity with frontal cortex (Baggio et al., 2015).”
    Quote in the paperSubstantial claim0 of 3 sources checked
    • cites Mori et al., 2014 source

      Not checked in the free run.

    • cites Holthoff et al., 2005 source

      Not checked in the free run.

    • cites Lanctôt et al., 2007 source

      Not checked in the free run.

  • May combine two claims.

    Findingcitation

    NPI Irritability, but not Agitation/Aggression, is associated with lower fractional anisotropy in anterior cingulate cortex in Alzheimer's disease.

    “In a study using DTI Tighe et al. (2012) reported that NPI Irritability (but not Agitation/Aggression) was associated with lower fractional anisotropy (FA) (suggesting decreased WM integrity) in ACC.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Tighe et al., 2012 source

      Not checked in the free run.

  • May combine two claims.

    Findingcitation

    Apathy severity in Alzheimer's disease is associated with higher levels of cerebrospinal fluid tau and phospho-tau but not cerebrospinal fluid Aβ1-42.

    “Apathy severity was associated with higher levels of CSF tau and phospho-tau but not CSF Aβ1–42.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Skogseth et al., 2008 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Findingcitation

    Lower cerebrospinal fluid taurine in Alzheimer's disease is associated with depression and overall neuropsychiatric symptoms.

    “The sole CSF study examined monoaminergic neurotransmitters, metabolites, and amino acids in 202 AD subjects reporting that lower CSF taurine was associated not only with depression, but also with overall NPS (Vermeiren et al., 2013).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Vermeiren et al., 2013 source

      Not checked in the free run.

  • May combine two claims.

    Findingcitation

    Delusions in Alzheimer's disease are associated with decreased perfusion in right anterior insula and decreased gray matter volume in left insula.

    “Delusions were also associated with decreased perfusion in right anterior insula (Matsuoka et al., 2010) and decreased GM volume in left insula (Nakaaki et al., 2013).”
    Quote in the paperSubstantial claim0 of 2 sources checked
    • cites Matsuoka et al., 2010 source

      Not checked in the free run.

    • cites Nakaaki et al., 2013

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Findingcitation

    Depression in Alzheimer's disease is associated with decreased gray matter volumes in left middle frontal cortex.

    “Hu et al. (2015) reported on a similar ADNI cohort of 202 subjects with MCI and 85 with AD, and found that NPI-Q Depression was associated with decreased GM volumes in left middle frontal cortex.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Hu et al., 2015

      Not checked in the free run.

  • May combine two claims.

    Findingreasoning

    Agitated Alzheimer's disease patients appear to overestimate and overreact to threats and be unable to modulate strong emotional responses.

    “agitated AD patients indeed appear to overestimate and overreact to threats and be unable to modulate strong emotional responses”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Findingcitation

    Depression in Alzheimer's disease is associated with reduced entorhinal cortical thickness at baseline and with accelerated atrophy in anterior cingulate cortex.

    “They found Depression to be associated with reduced entorhinal cortical thickness at baseline and with accelerated atrophy in ACC.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Zahodne et al., 2013 source

      Not checked in the free run.

  • May combine two claims.

    Interpretationreasoning

    Agitation in Alzheimer's disease arises out of deficits in regulating emotional responses and/or attentional resources, and may involve deficits in problem-solving.

    “These suggest that agitation in AD arises out of deficits in regulating emotional responses and/or attentional resources, and may involve deficits in problem-solving.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S1 (asserted), S4 (based).

    Interpretationreasoning

    The brain regions associated with neuropsychiatric symptoms in Alzheimer's disease are functionally linked as brain networks or circuits.

    “As several spatially disparate regions are associated with NPS, we hypothesize that these are in fact linked functionally as brain “networks” or “circuits,” terms that we use interchangeably.”
    • Also stated in: § 1. Background · hedged
      “While most of the evidence is associative at this point, the idea that regions associated with NPS are part of functional networks (circuits) is our central hypothesis.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S4 (based).

    Interpretationnone given

    Variability of brain network disruption by the Alzheimer's disease brain disease accounts for variability in neuropsychiatric symptom phenotypes.

    “Applying a similar approach to understanding NPS, we propose that variability of brain network disruption by the AD brain disease accounts for variability in NPS phenotypes.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationreasoning

    Agitation in Alzheimer's disease may constitute two different mechanisms, one due to deficits in affective regulation and the other due to deficits in executive function.

    “These may constitute two different mechanisms for agitation in AD, one due to deficits in affective regulation (emotional responses) and the other due to deficits in executive function (problem-solving).”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S4 (based).

    Interpretationreasoning

    Increased salience network connectivity in agitated Alzheimer's disease patients may reflect compensatory changes in network connectivity that account for reduction of default mode network connectivity.

    “The only published study on this reports increased SN connectivity in agitated AD patients, perhaps reflecting compensatory changes in network connectivity that account for reduction of DMN connectivity.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    There is evidence for the efficacy of dopaminergic agents for apathy in Alzheimer's disease.

    “there is evidence for the e3cacy of dopaminergic agents for apathy in AD (Rosenberg et al., 2013)”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Rosenberg et al., 2013 source

      Not checked in the free run.

  • May combine two claims.

    Interpretationnone given

    Current evidence does not clarify the temporal order of neurochemical changes versus circuit disruptions; one may precede the other or they may be simultaneous.

    “However, the current evidence does not clarify the temporal order of neurochemical changes vs. circuit disruptions, one may precede the other or they may be simultaneous processes.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S2 (checkable).

    Interpretationnone given

    We are only beginning to understand how the associated regions are connected at the white matter level.

    “we are only beginning to understand how these are in fact “connected” at the white matter level”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S1 (asserted).

    Interpretationreasoning

    Agitation in Alzheimer's disease may be due to alterations in the balance of the default mode network and salience network.

    “Since there are similarities between agitated AD patients and bvFTD in that both may be disinhibited and demonstrate poor social judgment, one might hypothesize that agitation in AD is due to alterations in the balance of DMN and SN.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S4 (based).

    Interpretationnone given

    There is insufficient evidence for depression or psychosis to develop cogent hypotheses.

    “There is insufficient evidence for depression or psychosis to develop cogent hypotheses.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Interpretationreasoning

    Damage to agitation circuits might cause a patient with agnosia to react to a family member as a stranger and become agitated.

    “Similarly, damage to agitation circuits might cause a patient with agnosia to react to a family member as a stranger and become agitated.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim. May combine two claims.

    Premisecitation

    Circuits underlying neuropsychiatric disorders give rise to neuropsychiatric symptoms either by intrinsic circuit dysfunction or by loss or aberrant regulation of circuits from ascending monoamine systems.

    “We have previously proposed that circuits underlying neuropsychiatric disorders give rise to NPS either by intrinsic circuit dysfunction or by loss or aberrant regulation of circuits from ascending monoamine systems (Lyketsos et al., 2004).”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Lyketsos et al., 2004 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S2 (checkable), S4 (based).

    Interpretationnone given

    We have good data to suggest regions and structures that may be associated with a behavior or symptom.

    “While we have good data to suggest regions and structures that may be associated with a behavior or symptom”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).

    Premisenone given

    Dopaminergic neurotransmission is thought to underlie many goal-directed behaviors including addiction.

    “Although dopaminergic neurotransmission is thought to underlie many goal-directed behaviors including addiction”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation

    Thalamocortical circuits, and most circuits connecting deep brain structures to cortex, are inhibitory.

    “thalamocortical circuits (and indeed most circuits connecting deep brain structures to cortex) are inhibitory (Nowrangi et al., 2014)”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Nowrangi et al., 2014 source

      Not checked in the free run.

  • May combine two claims.

    Interpretationreasoning

    Delusions in Alzheimer's disease are associated with core Alzheimer's disease neurodegenerative processes, especially with deficits in salience and the ability to focus brain resources to cope with emotionally charged states.

    “As well, they suggest that delusions are associated with core AD neurodegenerative processes along, especially with deficits in salience and the ability to focus brain resources to cope with emotionally charged states.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationcitation

    Specific circuit alterations underlie the link of Alzheimer's disease pathology with neuropsychiatric symptoms, with these associations being particularly compelling for agitation and apathy in specific circuits.

    “Our review of the data on the biology of NPS in AD suggests specific circuit alterations underlying the link of AD pathology with NPS, with these associations being particularly compelling for agitation and apathy in specific circuits (Fig. 1 and Fig. 2) given intriguing overlap with relevant brain circuits (Grupe and Nitschke, 2013).”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Grupe and Nitschke, 2013 source

      Not checked in the free run.

  • May combine two claims.

    Interpretationreasoning

    In agitation, the relevant circuits underlie inflated estimations of threat cost or probability, as well as maladaptive control of responses.

    “In the case of agitation, these circuits underlie inflated estimations of threat cost or probability, as well as maladaptive control of responses.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationreasoning

    One cannot map neuropsychiatric symptoms to deficits in single brain regions or to global neurochemical changes in the brain.

    “It is similarly evident that one cannot map NPS to deficits in single brain regions or to global neurochemical changes in the brain.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisenone given

    Agitation in Alzheimer's disease is associated with elevated tau and decreased acetylcholine and serotonin neurotransmission.

    “The neurochemical data on agitation in AD suggest it is associated with elevated tau and decreased acetylcholine and serotonin neurotransmission (all associated with the core neurodegenerative processes of AD).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisecitation

    In Alzheimer's disease, default mode network connectivity is decreased and salience network connectivity is increased, while in behavioral variant frontotemporal dementia the opposite is true.

    “Zhou et al. (2010) pointed out that in AD, DMN connectivity is decreased and SN is increased, while in bvFTD the opposite is true.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Zhou et al., 2010 source

      Not checked in the free run.

  • May combine two claims.

    Interpretationcitation

    Agitation in Alzheimer's disease involves miscalculation of the magnitude of potential threats, accompanied by increased threat attention and vigilance, and/or heightened reactivity to threat uncertainty.

    “Thus, agitation in AD involves miscalculation of the magnitude of potential threats, accompanied by increased threat attention and vigilance, and/or heightened reactivity to threat uncertainty (Grupe and Nitschke, 2013) (see their fig. 1a, 1b, and 1f).”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Grupe and Nitschke, 2013 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing).

    Interpretationreasoning

    Lack of interest, lack of initiative, and emotional blunting could be construed as manifestations of avoidance, as the patient seeks to avoid anxiety-provoking situations and thoughts.

    “Certainly lack of interest, lack of initiative, and emotional blunting could be construed as manifestations of avoidance, as the patient seeks to avoid anxiety-provoking situations and thoughts.”
    Quote in the paperNot a substantial claim
34 of 34
  • The paper relies on this without support.

    Understanding the etiopathogenesis of neuropsychiatric symptoms in Alzheimer's disease, particularly their links to the Alzheimer's disease brain disease, will help address the paucity of therapeutic options.

    “One of the reasons for the relative paucity of therapeutic options is the limited understanding of the etiopathogenesis of NPS in AD, in particular their links to the AD brain disease.”
1 of 1

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The citation lists haven’t been fetched yet

References 102 · Cited by 302

Authors
Rosenberg, P. B., Nowrangi, M. A., & Lyketsos, C. G.
Affiliations
Johns Hopkins University (US)
Corresponding author
Rosenberg, Paul B.
Venue
Molecular Aspects of Medicine
Publisher
Elsevier BV
Published
2015-06
Volume
43-44
Pages
25-37
ISSN
0098-2997 (ISSN-L)
OpenAlex
W638243159
Cited by
302
References
102
Citations by year
2026: 25 · 2025: 22 · 2024: 32 · 2023: 29 · 2022: 51 · 2021: 38 · 2020: 28 · 2019: 24 · 2018: 19 · 2017: 19 · 2016: 13 · 2015: 2
FWCI
2.43
Type
journal article
Language
en
Open access
Locations
  • Molecular Aspects of Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Institute on Aging (R01AG039384, P50AG005146)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
Keywords
neuropsychiatric symptoms, Alzheimer's disease, agitation, apathy, delusions, depression, brain circuits, artificial neural networks, frontal cortex, anterior cingulate cortex, posterior cingulate cortex, amygdala, hippocampus, emotion regulation, avoidance behavior
MeSH terms
Alzheimer Disease, Amygdala, Brain, Delusions, Depression, Gyrus Cinguli, Humans, Neuroimaging

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-09.

Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-09.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review